Chronic myeloid leukemia, BCR-ABL1-positive with CALR and MPL mutations

被引：7
|
作者：
Klairmont, M. M. [1 ]
Cheng, J. [1 ]
Schwartzberg, L. [2 ]
Ho, H. H. [3 ]
Gradowski, J. F. [1 ]
机构：
[1] Univ Tennessee, Dept Pathol & Lab Med, Hlth Sci Ctr, Memphis, TN 38163 USA
[2] Univ Tennessee, Div Hematol Oncol, Hlth Sci Ctr, Dept Med, Memphis, TN 38163 USA
[3] PathGroup, Nashville, TN USA
来源：
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY | 2018年 / 40卷 / 03期
关键词：
MYELOPROLIFERATIVE NEOPLASM; PRIMARY MYELOFIBROSIS; BCR-ABL1;
D O I：
10.1111/ijlh.12792
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E41 / E42
页数：2
相关论文
共 50 条
  • [31] BCR- ABL KINASE MUTATIONS TO IMATINIB RESISTANCE IN CHRONIC MYELOID LEUKEMIA
    Thungappa, S. Chiradoni
    Singh, T.
    Rashmi, N. R.
    Lokanatha, D.
    Rajshekar, H.
    Lakshmaiah, K. C.
    Babu, K. G.
    Suresh, T. M.
    ANNALS OF ONCOLOGY, 2010, 21 : 357 - 357
  • [32] BCR-ABL independent gene mutations in patients with chronic myeloid leukemia
    Schmidt, M.
    Rinke, J.
    Schaefer, V.
    Ziermann, J.
    Eigendorff, E.
    Hochhaus, A.
    Ernst, T.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 210 - 210
  • [33] CALR-mutated essential thrombocythemia evolving to chronic myeloid leukemia with coexistent CALR mutation and BCR-ABL translocation
    Bonzheim, Irina
    Mankel, Barbara
    Klapthor, Peter
    Schmidt, Janine
    Hinrichsen, Tanja
    Wachter, Oliver
    Fend, Falko
    Quintanilla-Martinez, Leticia
    BLOOD, 2015, 125 (14) : 2309 - 2311
  • [34] Calr plus Myelofibrosis/BCR-ABL Chronic Myeloid Leukemia Overlap Syndrome Treated with Asciminib
    Saal, Talia M.
    Pellegrino, Christine
    Ahmed, Tauseef
    Seiter, Karen
    Liu, Delong
    Steinberg, Amir
    BLOOD, 2023, 142
  • [35] BCR-ABL1-positive CML and BCR-ABL1-negative chronic myeloproliferative disorders: some common and contrasting features
    Cross, N. C. P.
    Daley, G. Q.
    Green, A. R.
    Hughes, T. P.
    Jamieson, C.
    Manley, P.
    Mughal, T.
    Perrotti, D.
    Radich, J.
    Skoda, R.
    Soverini, S.
    Vainchenker, W.
    Verstovesk, S.
    Villeval, J. -L
    Goldman, J. M.
    LEUKEMIA, 2008, 22 (11) : 1975 - 1989
  • [36] Frequency and Clonality of BCR-ABL Compound Mutations in Chronic Myeloid Leukemia
    Khorashad, Jamshid
    Kelley, Todd W.
    Szankasi, Philippe
    Adrian, Lauren T.
    Eide, Christopher A.
    Zabriskie, Matthew S.
    Lange, Thoralf
    Kraft, Ira L.
    Eiring, Anna M.
    O'Hare, Thomas
    Deininger, Michael W.
    BLOOD, 2011, 118 (21) : 1598 - 1599
  • [37] Dendritic cells for vaccination in BCR/ABL positive chronic myeloid leukemia.
    Westermann, J
    Richter, G
    Kopp, J
    Körner, I
    Döhner, H
    Döhner, K
    Dörken, B
    Pezzutto, A
    BLOOD, 1999, 94 (10) : 281B - 281B
  • [38] Basic knowledge on BCR-ABL1-positive extracellular vesicles
    Jurj, Ancuta
    Pasca, Sergiu
    Teodorescu, Patric
    Tomuleasa, Ciprian
    Berindan-Neagoe, Ioana
    BIOMARKERS IN MEDICINE, 2020, 14 (06) : 451 - 458
  • [39] The prevalence of JAK2, CALR, and MPL mutations in BCR-ABL1 rearrangement negative Iraqi patients
    Dayyeni, Aseel M. Al
    Al-Gailani, Bassam T.
    Mahdi, Mohammed Ghanim
    Khazeem, Mushtaq M.
    JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY, 2023, 30 (03): : E443 - E451
  • [40] The prevalence of JAK2, CALR, and MPL mutations in BCR-ABL1 rearrangement negative Iraqi patients
    Dayyeni, Aseel M. Al
    Al-Gailani, Bassam T.
    Mahdi, Mohammed Ghanim
    Khazeem, Mushtaq M.
    JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY, 2023, 30 (03): : E443 - E451
12345